Potent, long-acting bradykinin antagonists for a wide range of applications

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 719-724

  Stewart, John M ^a   Gera, Lajos ^a   Chan, Daniel C ^a   Whalley, Eric T ^b   Hanson, Wendy L ^b   Zuzack, John S ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Departments of New Leads Chemistry and Pharmacology   (United States)

Author keywords

Bradykinin; Bradykinin antagonists; Bradykinin receptors; Cancer; Inflammation; Small cell carcinoma of the lung

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR;

CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030724864     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-084     Document Type: Conference Paper

References (31)

1. Akbary, A.M., Wirth, K.J., and Schölkens, B.A. 1996. Efficacy and tolerability of Icatibant (HOE-140) in patients with moderately severe chronic bronchial asthma. Immunopharmacology, 33: 238-242.
2. Austin, C.E., Foreman, J.C., and Scadding, G.K. 1994. Reduction by HOE-140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage. Br. J. Pharmacol. 111: 969-971.
3. Bhoola, K., Figueroa, C.D., and Worthy, K. 1992. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44: 1-80.
4. Bunn, P.A., Chan, D., Stewart, J., Gera, L., Tolley, R., Jewett, P., Tagawa, M., Alford, C., Mochizuki, T., and Yanaihara, N. 1994. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Cancer Res. 54: 3602-3610.
5. Chan, D., Gera, L., Helfrich, B., Helm, K., Stewart, J., Whalley, E., and Bunn, P. 1996. Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology, 33: 201-204.
6. Cheronis, J.C., Whalley, E.T., Nguyen, K.T., Eubanks, S.R., Allen, L.G., Duggan, M.J., Loy, S.D., Bonham, K.A., and Blodgett, J.K. 1992. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J. Med. Chem. 35: 1563-1572.
7. Freedman, R., and Jarnagin, K. 1992. Cloning of a bradykinin B2 receptor: examination of the binding site by site-directed mutagenesis. Agents Actions, 38S/I: 487-496.
8. Herzig, M.C.S., and Leeb-Lundberg, L.M.F. 1995. The agonist binding site on the bovine bradykinin B2 receptor is adjacent to a sulfhydryl and is differentiated from the antagonist binding site by chemical cross-linking. J. Biol. Chem. 270: 20 591-20 598.
9. Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, S., Breipohl, G., König, W., and Schölkens, B.A. 1991. HOE-140 a new, potent and long acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol. 102: 769-773.
10. 2 antagonist: in vitro and in vivo studies. Can. J. Physiol. Pharmacol. 75. This issue.
11. Jarnagin, K., Bhakta, S., Zuppan, P., Yee, C., Ho, T., Phan, T., Tahilramani, R., Pease, J.H.B., Miller, A., and Freedman, R. 1996. Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists. J. Biol. Chem. 271: 28 277-28 286.
12. Kyle, D.J., Blake, P.R., Smithwick, D., Green, L.M., Martin, J.A., Sinsko, J.A., and Summers, M.F. 1993. NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal β-turns. J. Med. Chem. 36: 1450-1460.
13. Kyle, D.J., Chakravarty, S., Sinsko, J.A., and Stormann, T.M. 1994. A proposed model of bradykinin bound to the rat B2 receptor and its utility for drug design. J. Med. Chem. 37: 1347-1354.
14. Lammek, B., Wang, Y.-X., Gavras, I., and Gavras, J. 1991. A novel bradykinin antagonist with improved properties. J. Pharm. Pharmacol. 43: 887-888.
15. Maeda, H., Akaike, J.W., Noguchi, Y., and Sakata, Y. 1996. Bradykinin and nitric oxide in infectious disease and cancer. Immunopharmacology, 33: 222-230.
16. Marceau, F. 1995. Kinin B1 receptors: a review. Immunopharmacology, 30: 1-26.
17. Nardone J., and Hogan, P.G. 1994. Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding. Proc. Natl. Acad. Sci. U.S.A. 91: 4417-4421.
18. Novotny, E.A., Bednar, D.L., Connolly, M.A., Connor, J.R., and Stormann, T.M. 1994. Mutation of aspartate residues in the third extracellular loop of the rat B2 bradykinin receptor decreases affinity for bradykinin. Biochem. Biophys. Res. Commun. 201: 523-530.
19. 8]-BK and HOE-140, in two models of persistent hyperalgesia in the rat. Pain, 53: 191-197.
20. Regoli, D., Barabe, J., and Park, W.K. 1977. Receptors for bradykinin in rabbit aorta. Can. J. Physiol. Pharmacol. 55: 855-867.
21. Regoli, D., Drapeau, G., Rovero, P., Dion, S., and D'Orleans-Juste, P. 1986. The actions of kinin antagonists on B1 and B2 receptor systems. Eur. J. Pharmacol. 123: 61-66.
22. Rodell, T.C. 1996. The kallikrein/kinin system and kinin antagonists in trauma. Immunopharmacology, 33: 279-283.
23. Salvino, J.M., Seoane, P.R., Douty, B.D., Awad, M.M.A., Dolle, R.E., Houck, W.T., Faunce, D.M., and Sawutz, D.G. 1993. Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor. J. Med. Chem. 36: 2583-2584.
24. 14]Bombesin analogues function as small cell lung cancer bombesin receptor antagonists. Peptides, 12: 145-149.
25. Stewart, J.M. 1993. Roles for kinins in inflammation. Agents Actions, 42S: 145-157.
26. Stewart, J.M., and Vavrek, R.J. 1991. Chemistry of peptide B2 bradykinin antagonists. In Bradykinin antagonists. Edited by R.M. Burch. Pergamon Press, Oxford, England. pp. 51-96.
27. Stewart, J.M., Gera, L., Hanson, W., Zuzack, J.S., Burkard, M., McCullough, R., and Whalley, E.T. 1996. A new generation of bradykinin antagonists. Immunopharmacology, 33: 51-60.
28. Tallett, A., Chilvers, E.R., MacKinnon, A.C., Haslett, C., and Sethi, T. 1996. Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines. Peptides, 17: 665-673.
29. Vavrek, R.J., and Stewart, J.M. 1985. Competitive antagonists of bradykinin. Peptides, 6: 161-164.
30. Whalley, E.T., Hanson, W.L., Stewart, J.M., and Gera, L. 1997. Oral activity of peptide bradykinin antagonists following intragastric administration in the rat. Can. J. Physiol. Pharmacol. 75. This issue.
31. Woll, P.J., and Rozengurt, E. 1988. Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer. Br. J. Cancer, 57: 579-586.